logo
  

Short-Term Investor Stock ENTG Gains 74.6%

The stock, Entegris Inc. (ENTG), featured on our 'Short-Term Investor' on July 23, 2020, at an opening price of $65.29. On January 25, 2021, the stock touched a 52-week high of $114.00, representing a gain of 74.6%. ENTG closed yesterday's trade at $108.80.

Last month, the company reported Q4 GAAP net income of $86.6 million or $0.63 per share compared to $57.4 million or $0.42 per share last year. Non-GAAP net income was $97.1 million or $0.71 per share versus $74.6 million or $0.55 per share in the prior year period. Net sales rose to $517.5 million from $426.9 million a year ago.

For the first quarter ending April 3, 2021, the company expects net income of $83 million - $90 million, or $0.61 - $0.66 per share, non-GAAP net income of $94 million - $101 million, or $0.69 - $0.74 per share on sales of $510 million - $525 million.

Why we published this stock on July 23, 2020?

The company issued upbeat Q3 guidance, while reporting better-than-expected Q2 results.

Q3 Guidance

The company then expected Q3 GAAP net income of $70 million - $78 million, or $0.60 - $0.66 per share, non-GAAP income of $82 million - $90 million or $0.60 - $0.66 per share, on sales between $450 million and $475 million. Wall Street analysts then estimated earnings of $0.48 per share on revenue of $409.68 million for the quarter.

Q2 Results

The company's Q2 net income was $68.0 million or $0.50 per share versus $123.9 million or $0.91 per share last year. On a non-GAAP basis, net income increased to $81.6 million or $0.60 per share from $53.4 million or $0.39 per share reported a year ago. Net sales totaled $448.4 million, higher than the previous year's $378.9 million.

Analysts polled by Thomson Reuters expected earnings of $0.48 per share on revenue of $417.42 million for the quarter. Analysts' estimate typically exclude certain special items.

Free Sign Up
Free Sign Up

Short-Term Investor Top Perfomers
Pub. DateCompany% Gain
01/10/2018 TNDM + 696.14
05/08/2018 TREX + 211.39
05/17/2016 MIME + 207.12
09/02/2020 CAL + 205.29
01/07/2016 QUAD + 198.90
03/18/2021 UPST + 193.74
05/24/2016 EXEL + 185.08
08/08/2019 ACMR + 184.92
12/04/2020 SWBI + 167.45
01/30/2015 CORT + 161.51
08/13/2020 RVLV + 152.19
Complete Performance
Under the Radar Top Perfomers
Pub. DateCompany% Gain
10/15/2020 ORGO + 453.18
07/24/2020 CLFD + 130.11
04/27/2020 MDGS + 108.50
02/20/2013 IKNX + 99.41
08/13/2014 INGN + 98.42
11/11/2014 CYAN + 89.14
02/22/2019 BOOM + 87.02
12/11/2014 INTL + 86.33
03/07/2019 FLY + 81.83
10/23/2014 OFLX + 81.26
Complete Performance
Emerging Biostocks Top Perfomers
Pub. DateCompany% Gain
04/19/2017 MRTX + 4951
11/23/2017 ARGX + 1115
07/17/2018 AMRN + 737
04/05/2017 MYOK + 734
01/19/2020 DMTK + 628
10/03/2019 CNST + 552
03/26/2020 MRNA + 548
05/11/2020 TWST + 450
09/03/2019 APLT + 437
07/01/2020 CRDF + 415
11/03/2019 THOR + 362
09/21/2018 CCXI + 339
08/06/2019 ZLAB + 276
10/12/2020 EVLO + 262
04/08/2019 SOLY + 170
07/08/2019 PRNB + 152
12/07/2020 SYRS + 80
Complete Performance
Free Sign Up